Clonidine XR for children with ADHD and oppositional behavior
Part of Mental health clinical trials.
This study tests a long-acting form of the medicine clonidine (called Onyda XR) to see if it safely reduces symptoms of ADHD and oppositional defiant disorder in children. Children who join will take the study medicine or a placebo for a set period, and their symptoms will be tracked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 and 12 years old.
- Your child must have been diagnosed with both ADHD and ODD by a mental health professional.
- If your child is currently taking ADHD medicine, they'll need to stop it for 1–2 weeks before starting the study.
- Your child must be generally healthy, with no major heart, liver, or kidney problems, and no history of suicidal thoughts or self-harm.
- You (the parent or guardian) must be able to read and speak English and be willing to commit to the study schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how ADHD stimulant medicine may change disruptive behaviors like aggression, tantrums, or refusing instructions. It may help clinicians understand whether stimulant dosing is supporting both ADHD symptoms and day-to-day behavior.
This study tests a medication called Foquest to see if it helps older adults with ADHD. It aims to improve attention and reduce hyperactivity or impulsivity in people aged 65 and above.
This study tests whether viloxazine extended-release can reduce ADHD symptoms in children ages 4–5. It also checks safety in preschool-age kids, including heart and nervous-system side effects.
This study tests if Jornay PM, a long-acting ADHD medication, helps control symptoms, focus, and emotions throughout the day and into the early evening in adults with ADHD. It is an open-label study, meaning everyone knows they are getting the medication, and then they are randomly assigned to different observation groups.
This pilot study tests a remote monitoring program (RAMP) for children with ADHD who are starting or restarting stimulant medication. It aims to see if using a smartphone app to track symptoms helps providers and families manage care.
This Phase 3 study tests whether a non-painful brain stimulation method called tDCS can improve ADHD symptoms in children, and whether it helps over the long term. Your child may be able to join if they are 7–14 with a confirmed ADHD diagnosis and meet symptom and testing scores.
Hear when a new ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.